Literature DB >> 30259912

The 2015 World Health Organization Classification of lung tumors: new entities since the 2004 Classification.

M C Mengoli1, F R Longo2, F Fraggetta2, A Cavazza3, A Dubini4, G Alì5, F Guddo6, E Gilioli7, G Bogina8, N Nannini9, F Barbisan10, N De Rosa11, G Falconieri12, G Rossi13, P Graziano14.   

Abstract

In the last few years different new pulmonary neoplastic lesions have been recognised and some of them, namely NUT carcinoma, PEComatous tumors, pneumocytic adenomyoepithelioma, pulmonary myxoid sarcoma, myoepithelial tumors/carcinomas entered in the last 2015-WHO classification of lung tumors. In addition angiomatoid fibrous histiocytoma and ciliated muconodular papillary tumor have been morphologically and genetically characterized albeit not yet included in the 2015-WHO classification. In the present paper we summarised the clinical, morphological, immunohistochemical and molecular features of these new entities. The knowledge of key histologic and molecular characteristics may help pathologists in achieving a correct diagnosis thus leading to an adequate therapeutic approach.
Copyright © 2018 Società Italiana di Anatomia Patologica e Citopatologia Diagnostica, Divisione Italiana della International Academy of Pathology.

Entities:  

Keywords:  Angiomatoid fibrous histiocytoma; Epithelial-myoepithelial carcinoma; Myxoid sarcoma; NUT carcinoma; PEComatous tumors

Mesh:

Year:  2018        PMID: 30259912

Source DB:  PubMed          Journal:  Pathologica        ISSN: 0031-2983


  15 in total

Review 1.  Pulmonary Myoepithelial Tumors With Exuberant Reactive Pneumocytes: Proposed Reclassification of So-called Pneumocytic Adenomyoepithelioma.

Authors:  Lisi Yuan; Nora Katabi; Cristina R Antonescu; Andrew Golden; William D Travis; Natasha Rekhtman
Journal:  Am J Surg Pathol       Date:  2020-01       Impact factor: 6.394

2.  Epidemiology and survival outcomes in adenosquamous carcinoma: a population-based study.

Authors:  Chuang Cheng; Zan Luo; Wei Xiong; Zhongquan Shi; Hui Tan
Journal:  Int J Colorectal Dis       Date:  2022-06-09       Impact factor: 2.796

3.  Treatments for combined small cell lung cancer patients.

Authors:  Jiaxi He; Songhui Xu; Hui Pan; Shuben Li; Jianxing He
Journal:  Transl Lung Cancer Res       Date:  2020-10

4.  Application of an elevated plasma D-dimer cut-off value improves prognosis prediction of advanced non-small cell lung cancer.

Authors:  Chong Chen; Jianhua Li; Jing Li; Xu Wang; Xiaoyan Wang; Na Du; Li Ren
Journal:  Ann Transl Med       Date:  2020-09

5.  The surgical management of early-stage lung adenocarcinoma: is wedge resection effective?

Authors:  Ying Ji; Guangyu Bai; Bin Qiu; Liang Zhao; Jing Zhou; Qi Xue; Shugeng Gao
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

6.  Identification of a multidimensional transcriptome prognostic signature for lung adenocarcinoma.

Authors:  Jing Ye; Hui Liu; Zhi-Li Xu; Ling Zheng; Rong-Yu Liu
Journal:  J Clin Lab Anal       Date:  2019-08-11       Impact factor: 2.352

7.  Co-existence of well-differentiated fetal adenocarcinoma of the lung with tuberculosis in a young female: A rare case report.

Authors:  Fengzhu Guo; Jiantao Wang; Haoyue Hu; Xiaoxiao Xie; Kuncheng Liu; Feng Luo
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

8.  Cholesterol synthesis disruption combined with a molecule-targeted drug is a promising metabolic therapy for EGFR mutant non-small cell lung cancer.

Authors:  Youli Luo; Yunpeng Yang; Peijian Peng; Jianhua Zhan; Zhihui Wang; Zhiquan Zhu; Zhonghan Zhang; Lin Liu; Wenfeng Fang; Li Zhang
Journal:  Transl Lung Cancer Res       Date:  2021-01

9.  TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC.

Authors:  Ming Lou; Zhaojia Gao; Tao Zhu; Xiaoliang Mao; Yeming Wang; Kai Yuan; Jichun Tong
Journal:  Oncol Lett       Date:  2019-12-10       Impact factor: 2.967

10.  Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening.

Authors:  Zhichao Li; Youhui Qian; Wujiao Li; Lisa Liu; Lei Yu; Xia Liu; Guodong Wu; Youyu Wang; Weibin Luo; Fuyuan Fang; Yuchen Liu; Fei Song; Zhiming Cai; Wei Chen; Weiren Huang
Journal:  iScience       Date:  2020-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.